Rather than through these canonical signaling pathways that regulate c-Jun, we established here that c-Jun is directly phosphorylated and activated by TOPK in EGFR-TKI-refractory lung cancer cells, leading to the transcriptional activation of AP-1 target genes such as CCND1 and CDC2 [41, 42]. This evidence concerns the gene EGFR and lung carcinoma.